Treatment Registry
TR-0717 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Luci · Oral tablet · every compounded tirzepatide record

What you actually pay

Per month

$145

Medication · Oral Tirzepatide, 12-month plan paid upfront$145

Added from the figures recorded below.

Price

TermPer monthCharged today
Oral Tirzepatide, 12-month plan paid upfront

Oral Tirzepatide Get a personalised oral tirzepatide plan. As low as $145*

source

Per month$145Charged today$145
Visit Luci

We earn nothing from this link. Luci has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

Cancellation“You may cancel your subscription at any time up by emailing ask@lucidirect.com or directly through your online account. Cancellation will take effect at the end of the current subscription period.”

Not yet checked: pharmacy, states, prescriber, membership and consult fee.

Recorded from lucirx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026States field intentionally left not-found rather than 'listed': the only explicit state statement found is an EXCLUSION list (8 states/DC not served), not a coverage list -- recording it as coverage would invert the claim. The Terms & Conditions page states in all caps 'ANY APPLICABLE FEES AND OTHER CHARGES ARE NOT REFUNDABLE IN WHOLE OR IN PART' (a 'NO REFUND POLICY'), which directly contradicts the separate /refund-policy page's advertised '6-month money-back guarantee' on GLP-1 treatments -- a real contradiction between the site's own two legal pages. The Terms page also refers to the company operating 'www.lucidirect.com' rather than lucirx.com, though lucirx.com's own header/footer consistently say 'Luci.'

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0717
Readings
1

Related records

What else Luci sells

All Luci programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Luci compounded tirzepatide (TR-0717). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0717

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.